Vaccine shows therapeutic promise against advanced melanoma
Monday, June 1, 2009 - 09:56
in Health & Medicine
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.
Read the whole article on Physorg
More from Physorg
Related
- Vaccine shows therapeutic promise against advanced melanomaMon, 1 Jun 2009, 9:44:24 EDT
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT
- Study shows cancer vaccines led to long-term survival for patients with metastatic melanomaTue, 28 Jul 2009, 13:55:44 EDT
- Novel 4-drug combination proves safe for lung cancer treatmentThu, 13 Nov 2008, 10:30:54 EST
- M. D. Anderson study finds dramatic increase in metastatic colon cancer survivalTue, 26 May 2009, 16:50:40 EDT